Published in Hum Mutat on January 01, 1997
Glycogen storage disease type III-hepatocellular carcinoma a long-term complication? J Hepatol (2006) 1.62
Echocardiographic manifestations of Glycogen Storage Disease III: increase in wall thickness and left ventricular mass over time. Genet Med (2010) 0.85
Mutation Analysis in Glycogen Storage Disease Type III Patients in the Netherlands: Novel Genotype-Phenotype Relationships and Five Novel Mutations in the AGL Gene. JIMD Rep (2012) 0.82
Two new mutations in the 3' coding region of the glycogen debranching enzyme in a glycogen storage disease type IIIa Ashkenazi Jewish patient. J Inherit Metab Dis (1998) 0.80
SINE indel polymorphism of AGL gene and association with growth and carcass traits in Landrace x Jeju Black pig F(2) population. Mol Biol Rep (2009) 0.80
Novel mutations in two Japanese cases of glycogen storage disease type IIIa and a review of the literature of the molecular basis of glycogen storage disease type III. J Inherit Metab Dis (2000) 0.78
Spectrum of AGL mutations in Chinese patients with glycogen storage disease type III: identification of 31 novel mutations. J Hum Genet (2016) 0.75
Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology (2006) 5.67
A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med (1998) 5.06
Mechanisms of epithelial cell-cell adhesion and cell compaction revealed by high-resolution tracking of E-cadherin-green fluorescent protein. J Cell Biol (1998) 5.03
Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J Exp Med (1998) 4.65
A surface protease and the invasive character of plague. Science (1992) 4.44
Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial. Genet Med (2001) 3.60
Glycogen storage disease in adults. Ann Intern Med (1994) 3.58
New paths in human cancer serology. J Exp Med (1998) 3.12
Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proc Natl Acad Sci U S A (2000) 3.00
Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease. J Pediatr (2006) 2.97
Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Int J Cancer (2001) 2.95
Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. Proc Natl Acad Sci U S A (2000) 2.79
Predictors of readmission among elderly survivors of admission with heart failure. Am Heart J (2000) 2.71
Factors affecting synthesis of ascorbic acid in cress seedlings. 2. Ascorbic acid synthesis in relation to sugar formation. Biochem J (1949) 2.46
Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical events. Int J Cancer (1999) 2.26
Microstructural fingerprints of phase transitions in shock-loaded iron. Sci Rep (2013) 2.17
Reliability of reported sunburn history in a case-control study of cutaneous malignant melanoma. Am J Epidemiol (1995) 2.05
Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration. Proc Natl Acad Sci U S A (1987) 2.05
Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer. Proc Natl Acad Sci U S A (2000) 2.02
Genetic analysis of enterovirus 71 isolated from fatal and non-fatal cases of hand, foot and mouth disease during an epidemic in Taiwan, 1998. Virus Res (2000) 1.95
Mapping of RNA accessible sites for antisense experiments with oligonucleotide libraries. Nat Biotechnol (1998) 1.93
Antigens recognized by autologous antibody in patients with renal-cell carcinoma. Int J Cancer (1999) 1.91
Cornstarch therapy in type I glycogen-storage disease. N Engl J Med (1984) 1.88
Evasion of immune responses to introduced human acid alpha-glucosidase by liver-restricted expression in glycogen storage disease type II. Mol Ther (2005) 1.87
A mouse mutant p53 product recognized by CD4+ and CD8+ T cells. Proc Natl Acad Sci U S A (1994) 1.86
Variations in KCNQ1 are associated with type 2 diabetes and beta cell function in a Chinese population. Diabetologia (2009) 1.83
Predicting one-year mortality among elderly survivors of hospitalization for an acute myocardial infarction: results from the Cooperative Cardiovascular Project. J Am Coll Cardiol (2001) 1.83
Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer (1998) 1.82
Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators. Am J Physiol Endocrinol Metab (2002) 1.82
Correlates and impact on outcomes of worsening renal function in patients > or =65 years of age with heart failure. Am J Cardiol (2000) 1.81
Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL. J Immunol (2000) 1.76
Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma. Proc Natl Acad Sci U S A (1995) 1.75
A prognostic rule for elderly patients admitted with community-acquired pneumonia. Am J Med (1999) 1.74
Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7. Int J Cancer (2001) 1.71
Comparing AMI mortality among hospitals in patients 65 years of age and older: evaluating methods of risk adjustment. Circulation (1999) 1.69
Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression. Cancer Immun (2001) 1.69
Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma. J Exp Med (2000) 1.67
Quality of care for patients hospitalized with heart failure at academic medical centers. Am Heart J (1999) 1.65
Identification and characterization of a prostaglandin transporter. Science (1995) 1.65
Human glycogen debranching enzyme gene (AGL): complete structural organization and characterization of the 5' flanking region. Genomics (1996) 1.63
Glycogen storage disease type III-hepatocellular carcinoma a long-term complication? J Hepatol (2006) 1.62
Expression of MAGE-antigens in normal tissues and cancer. Int J Cancer (2000) 1.60
SSX: a multigene family with several members transcribed in normal testis and human cancer. Int J Cancer (1997) 1.60
Nuclear-cytoplasmic transport and VAI RNA-independent translation of influenza viral messenger RNAs in late adenovirus-infected cells. Cell (1984) 1.57
Immunoreactivity for A103, an antibody to melan-A (Mart-1), in adrenocortical and other steroid tumors. Am J Surg Pathol (1998) 1.55
Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood. Am J Hum Genet (1993) 1.52
A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues. Am J Surg Pathol (1998) 1.51
Lack of evidence for an association between alpha-adducin and blood pressure regulation in Asian populations. Am J Hypertens (2000) 1.51
Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J Immunol (1998) 1.50
Genome-wide association study of bipolar I disorder in the Han Chinese population. Mol Psychiatry (2010) 1.49
Aspirin and angiotensin-converting enzyme inhibitors among elderly survivors of hospitalization for an acute myocardial infarction. Arch Intern Med (2001) 1.48
Variations in and correlates of length of stay in academic hospitals among patients with heart failure resulting from systolic dysfunction. Am J Manag Care (1999) 1.47
Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-alpha-glucosidase. Proc Natl Acad Sci U S A (1999) 1.46
Preparation of poly(glycolic acid) bonded fiber structures for cell attachment and transplantation. J Biomed Mater Res (1993) 1.44
Improved fluorescence and dual color detection with enhanced blue and green variants of the green fluorescent protein. J Biol Chem (1998) 1.43
Efficacy, safety and medication cost implications of adalimumab 40 mg weekly dosing in patients with psoriasis with suboptimal response to 40 mg every other week dosing: results from an open-label study. Br J Dermatol (2012) 1.42
The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a. Eur J Hum Genet (1999) 1.42
CT10: a new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis. Int J Cancer (2000) 1.42
Structural analysis of TL genes of the mouse. Proc Natl Acad Sci U S A (1985) 1.41
Direct and regulated interaction of integrin alphaEbeta7 with E-cadherin. J Cell Biol (1998) 1.40
Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle. J Clin Invest (1996) 1.40
Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library. Cancer Res (2001) 1.39
Glycogen storage disease types I and II: treatment updates. J Inherit Metab Dis (2007) 1.39
Beneficial effects of angiotensin-converting enzyme inhibitors during acute revascularization. Ann Thorac Surg (1998) 1.38
Brain abscess in glycogen storage disease type Ib. Acta Paediatr Scand (1991) 1.38
Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele. Proc Natl Acad Sci U S A (2000) 1.36
Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia. Gene Ther (2006) 1.35
Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail. J Clin Invest (1998) 1.34
Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours. Br J Cancer (2000) 1.34
Position-dependent ATT initiation during plant pararetrovirus rice tungro bacilliform virus translation. J Virol (1996) 1.31
Liver transplantation for glycogen storage disease types I, III, and IV. Eur J Pediatr (1999) 1.30
Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9. Cancer Lett (2000) 1.30
A gene on chromosome 11q23 coding for a putative glucose- 6-phosphate translocase is mutated in glycogen-storage disease types Ib and Ic. Am J Hum Genet (1998) 1.28
Preservation of the thin distal urethra in hypospadias repair. J Urol (2000) 1.27
Human lung cancer antigens recognized by autologous antibodies: definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3. Cancer Res (1998) 1.27
Purification of acetylcholinesterase by affinity chromatography and determination of active site stoichiometry. J Biol Chem (1972) 1.26
The incidence of coronary artery disease in patients with symptomatic bradyarrhythmias. Jpn Heart J (2001) 1.25
Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy. Ann Intern Med (1992) 1.25
Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: basis for polyvalent CT vaccine strategies. Int J Cancer (1998) 1.25
Expression of SSX genes in human tumors. Int J Cancer (1998) 1.24
Hepatic and neuromuscular forms of glycogen storage disease type IV caused by mutations in the same glycogen-branching enzyme gene. J Clin Invest (1996) 1.24
Serological cloning of a melanocyte rab guanosine 5'-triphosphate-binding protein and a chromosome condensation protein from a melanoma complementary DNA library. Cancer Res (2000) 1.23
Cloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA(hPGT). J Clin Invest (1996) 1.23
Assignment of the human glycogen debrancher gene to chromosome 1p21. Genomics (1992) 1.22
Acylcarnitines in fibroblasts of patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and other fatty acid oxidation disorders. J Inherit Metab Dis (2000) 1.22
Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III. J Pediatr (1990) 1.22
Phospholipid hydroperoxide glutathione peroxidase activity of human glutathione transferases. Biochem J (1998) 1.22
R1193Q of SCN5A, a Brugada and long QT mutation, is a common polymorphism in Han Chinese. J Med Genet (2005) 1.21
Mutations in the glucose-6-phosphatase gene are associated with glycogen storage disease types 1a and 1aSP but not 1b and 1c. J Clin Invest (1995) 1.20
Association of genetic variants of NOS1AP with type 2 diabetes in a Chinese population. Diabetologia (2009) 1.20
High-level production of recombinant human lysosomal acid alpha-glucosidase in Chinese hamster ovary cells which targets to heart muscle and corrects glycogen accumulation in fibroblasts from patients with Pompe disease. Proc Natl Acad Sci U S A (1996) 1.18
Follicle-stimulating hormone receptor is expressed in human ovarian surface epithelium and fallopian tube. Am J Pathol (1996) 1.17
Conjugation position of quercetin glucuronides and effect on biological activity. Free Radic Biol Med (2000) 1.17
Invasive neuroendocrine carcinoma of the breast: a prognostic research of 107 Chinese patients. Neoplasma (2013) 1.17
Molecular characterization of glycogen storage disease type III. Curr Mol Med (2002) 1.17
Recognition of the core RNA promoter for minus-strand RNA synthesis by the replicases of Brome mosaic virus and Cucumber mosaic virus. J Virol (2000) 1.17
Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade. Cancer Res (2001) 1.15
Liquid chromatographic assay for a glucose tetrasaccharide, a putative biomarker for the diagnosis of Pompe disease. Anal Biochem (2000) 1.15
Transgenic mice with inactive alleles for procollagen N-proteinase (ADAMTS-2) develop fragile skin and male sterility. Biochem J (2001) 1.14